Cargando…

Upregulated FADD is associated with poor prognosis, immune exhaustion, tumor malignancy, and immunotherapy resistance in patients with lung adenocarcinoma

BACKGROUND: FAS-associated death structural domain (FADD) proteins are important proteins that regulate apoptosis and are also involved in many nonapoptotic pathways in tumors. However, how dysregulated FADD affects the development of lung adenocarcinoma (LUAD) remains unknown. METHOD: Transcriptome...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Miao, He, Yingying, Xu, Jian, Zhang, Youcai, Cao, Xiaoyu, Wang, Li, Luo, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476093/ https://www.ncbi.nlm.nih.gov/pubmed/37671047 http://dx.doi.org/10.3389/fonc.2023.1228889

Ejemplares similares

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle
por: Albahde, Mugahed Abdullah Hasan, et al.
Publicado: (2020)

Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
por: Wang, Mingyue, et al.
Publicado: (2019)

GPR115 Contributes to Lung Adenocarcinoma Metastasis Associated With LAMC2 and Predicts a Poor Prognosis
por: Wang, Yingjing, et al.
Publicado: (2020)

Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma
por: Zou, Zhengrong, et al.
Publicado: (2022)

Upregulation of Long Non-Coding RNA GCC2-AS1 Facilitates Malignant Phenotypes and Correlated With Unfavorable Prognosis for Lung Adenocarcinoma
por: Yu, Fengqiang, et al.
Publicado: (2021)

FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L
por: Zhou, Suna, et al.
Publicado: (2021)

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia
por: Cheng, Zhiheng, et al.
Publicado: (2020)

Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma
por: Huang, Zigao, et al.
Publicado: (2021)

Perineural Invasion Is a Significant Indicator of High Malignant Degree and Poor Prognosis in Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Bai, Liuyang, et al.
Publicado: (2022)

Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion?
por: Chiruvella, Varsha, et al.
Publicado: (2022)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

Actinomycin D Induces Hepatocyte Cell Death and Upregulation of FADD/MORT1
por: Kim, Peter K.M., et al.
Publicado: (2001)

FADD adaptor in cancer
por: Tourneur, Léa, et al.
Publicado: (2005)

Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma
por: Huang, Xinyang, et al.
Publicado: (2022)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2020)

T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
por: Tang, Lu, et al.
Publicado: (2021)

Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Wang, Juan, et al.
Publicado: (2022)

Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients
por: Wen, Wei, et al.
Publicado: (2022)

Loss of HES-1 Expression Predicts a Poor Prognosis for Small Intestinal Adenocarcinoma Patients
por: Kim, Jeong Won, et al.
Publicado: (2020)

Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma
por: Wang, Juan, et al.
Publicado: (2022)

Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients
por: Zhang, Yawei, et al.
Publicado: (2021)

Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies
por: He, Jian, et al.
Publicado: (2023)

Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma
por: Liang, Yingkuan, et al.
Publicado: (2020)

Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma
por: Peng, Wenguang, et al.
Publicado: (2023)

Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA
por: Xue, Yuwen, et al.
Publicado: (2023)

ADT-OH, a hydrogen sulfide-releasing donor, induces apoptosis and inhibits the development of melanoma in vivo by upregulating FADD
por: Cai, Fangfang, et al.
Publicado: (2020)

High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer
por: Zhao, Huishan, et al.
Publicado: (2019)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2021)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ot728gj5ai3k3qpn67rbj5o61